Roche | Stories

Patients and science are at the heart of everything we do. It is through stories of hope, innovation, collaboration and medical breakthroughs that we truly measure the reach and impact of our work.
Learn about retinal vein occlusion (RVO), the second most common cause of vision loss due to retinal vascular diseases. Discover its signs, risks factors and the current treatment options available.
Explore how health innovation can improve lives, strengthen economies and unlock socioeconomic value, with new WifOR research, supported by Roche, on breast cancer, multiple sclerosis and retinal diseases.
Rising to 6th in the 2026 Access to Medicine Index: Discover how we are expanding equitable access to our medicines and diagnostics.
Roche is exploring the expanding scope of immunology therapy
Prof Loveday’s perspective on recognising the early signs of Alzheimer’s disease and how an early diagnosis, memory strategies and planning ahead helped her mother live well with Alzheimer’s.
Three diseases. One mission. Roche combines breakthrough technologies with deep immunology expertise and real-world data to transform treatment for lupus, IBD, and COPD
How describing the structural cells of tissues sheds new light on autoimmune disease
Discover how relapsing and progressive biology drive multiple sclerosis (MS). Learn how crossing the blood-brain barrier to target chronic inflammation helps prevent disability progression.
Discover the fresh thinking behind Roche’s KRAS G12C research and how scientists approached one of cancer research’s toughest targets from a different angle.
Explore evolving Alzheimer's diagnostic options. Learn how blood biomarker technology innovations like pTau217 are replacing uncertainty with timely clarity for patients and clinicians.
Roche at the World Health Summit 2026. As global health leaders gather in Berlin for the World Health Summit 2026, we have a vital opportunity to address a fundamental question: how do we shift healthcare from being treated as a short-term budget line to a primary driver of economic stability?
The 2026 Ophtha Innovation Challenge (OIC) seeks scalable solutions to improve DME care in underserved regions, alongside global initiatives to optimize Real-World Evidence (RWE) ecosystems.
Discover how Roche and Genentech's new Boston Innovation Center combines CVRM research, AI, and Harvard collaboration to develop transformative medicines for patients
The World Cancer Congress 2026 advances global cancer care through flexible models, early detection, and equity. Roche’s diagnostics and medicines offer a full perspective from detection to ongoing care.
As a young, fit black mom, Rhonda Monroe’s heart attack went undiagnosed for a week. Cardiac biomarkers could have led to faster diagnosis and treatment.
Discover the symptoms, risk factors and treatment options of uveitic macular edema (UME), a serious eye disease that can cause vision loss and blindness.
Explore how HPV self-collection gives OB-GYNs new options to screen underserved patients, overcome care barriers, and advance cervical cancer elimination.
Showcasing the opportunities to optimise lung cancer care for elderly and frail patients
Expanding the Possible: Through science, clinical practice & care delivery initiatives, the Ophthalmology Network brings clinicians & leaders together to learn, connect & grow, supporting progress in eyecare.
Shape the future of vision. Connect with emerging global peers, accelerate your scientific growth, and unlock world-class clinical mentorship with the Leading Edge Incubator.
Learn about retinal vein occlusion (RVO), the second most common cause of vision loss due to retinal vascular diseases. Discover its signs, risks factors and the current treatment options available.
Explore how health innovation can improve lives, strengthen economies and unlock socioeconomic value, with new WifOR research, supported by Roche, on breast cancer, multiple sclerosis and retinal diseases.
Roche is exploring the expanding scope of immunology therapy
Three diseases. One mission. Roche combines breakthrough technologies with deep immunology expertise and real-world data to transform treatment for lupus, IBD, and COPD
How describing the structural cells of tissues sheds new light on autoimmune disease
Rising to 6th in the 2026 Access to Medicine Index: Discover how we are expanding equitable access to our medicines and diagnostics.
The 2026 Ophtha Innovation Challenge (OIC) seeks scalable solutions to improve DME care in underserved regions, alongside global initiatives to optimize Real-World Evidence (RWE) ecosystems.
Discover how Roche and Genentech's new Boston Innovation Center combines CVRM research, AI, and Harvard collaboration to develop transformative medicines for patients
A caregiver shares her father-in-law’s journey with hypertension, showing how its underestimated risk led to life-changing cardiac events and how continuous, remote monitoring helped restore stability, confidence, and quality of life for him and more generally, the wider family.
In an increasingly interconnected world, reliance is a vital step toward delivering life-changing diagnostics solutions to patients everywhere.
At the heart of every accurate diagnosis lies pathology—the study of tissues and cells to identify the causes of diseases. The digital revolution is injecting new speed and precision into how we understand and identify diseases.
Explore how health innovation can improve lives, strengthen economies and unlock socioeconomic value, with new WifOR research, supported by Roche, on breast cancer, multiple sclerosis and retinal diseases.
Rising to 6th in the 2026 Access to Medicine Index: Discover how we are expanding equitable access to our medicines and diagnostics.
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not tak